Sheri Roggy, OD
Optometrist · Iowa City, IANPI 1457324477
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,006 of the $3,466 with a category attached, or 86.7%. 18 manufacturers reported payments, led by Lumenis BE Inc at 40.6% of the total. 2025 is the largest year on record at $1,715, more than ten times the $150 reported in 2019. Among optometrist clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $38.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE Inc$1K
- Bausch & Lomb Americas Inc.$660
- Alcon$382
- Bausch & Lomb, A Division Of Bausch Health US, LLC$180
- Tarsus Pharmaceuticals, Inc.$140
- Biotissue Holdings Inc.$127
- plus $572 from 12 others
What the payments were for
- Speaking & faculty fees$42512%
- Food & beverage$3,00687%
- Education$181%
- Entertainment$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE Inc | 2 | $1,406 |
| Bausch & Lomb Americas Inc. | 41 | $660 |
| Alcon | 13 | $382 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $180 |
| Tarsus Pharmaceuticals, Inc. | 6 | $140 |
| Biotissue Holdings Inc. | 6 | $127 |
| AbbVie | 1 | $113 |
| Coopervision Inc. | 4 | $92 |
| Johnson & Johnson Vision Care, Inc. | 2 | $83 |
| Sight Sciences, Inc. | 1 | $83 |
| Oculus, Inc. | 1 | $77 |
| LKC Technologies, Inc. | 1 | $28 |
| Quidel Corporation | 1 | $28 |
| Optos, Inc. | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Oyster Point Pharma, Inc. | 1 | $15 |
| Novartis | 1 | $12 |
| Topcon Healthcare, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,466 in reported general payments places this provider in the 95th percentile of 559 optometrist providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MieboPerfluorohexyloctane/Pf | 27 | $34,809 |
| XdemvyLotilaner | 12 | $22,089 |
| RestasisCyclosporine | 15 | $19,544 |
| XiidraLifitegrast | 16 | $14,642 |
| LumiganBimatoprost | 41 | $11,891 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 17 | $3,503 |
| Timolol Maleate | 53 | $1,695 |
| Latanoprost | 54 | $463 |
| MoxifloxacinMoxifloxacin Hcl | 17 | $315 |
| Doxycycline Hyclate | 12 | $117 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Miebo, Xiidra | $660 | $49,45143 claims |
| AbbVieRestasis, Lumigan | $113 | $31,43556 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $140 | $22,08912 claims |
| AlconSimbrinza | $382 | $3,50317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 559 optometrist providers in Iowa.
Other optometrist in Iowa City
- Christine SindtIowa City$5K
- Marcus NoyesIowa City$3K
- Brandon StalzerIowa City$3K
- Sean OneillIowa City$3K
- Rachel HutchinsIowa City$2K
- Sara ButterworthCoralville$191K
- Ethan HuismanWaukee$111K
- Kelsi SawatzkyWest Des Moines$26K
- Heidi BellClive$19K
- Jennifer DenhartogClive$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.